MA44057A - Produit combiné - Google Patents
Produit combinéInfo
- Publication number
- MA44057A MA44057A MA044057A MA44057A MA44057A MA 44057 A MA44057 A MA 44057A MA 044057 A MA044057 A MA 044057A MA 44057 A MA44057 A MA 44057A MA 44057 A MA44057 A MA 44057A
- Authority
- MA
- Morocco
- Prior art keywords
- combined product
- combined
- product
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1522232.6A GB201522232D0 (en) | 2015-12-16 | 2015-12-16 | Combination product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA44057A true MA44057A (fr) | 2018-10-24 |
Family
ID=55274872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA044057A MA44057A (fr) | 2015-12-16 | 2016-12-16 | Produit combiné |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10799494B2 (fr) |
| EP (1) | EP3389659A1 (fr) |
| CN (1) | CN108697705A (fr) |
| GB (1) | GB201522232D0 (fr) |
| MA (1) | MA44057A (fr) |
| WO (1) | WO2017103615A1 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018084809A1 (fr) * | 2016-11-02 | 2018-05-11 | Nanyang Technological University | Méthodes permettant le traitement ou la prévention d'infections mycobactériennes |
| CN111372921B (zh) | 2017-09-13 | 2023-12-01 | 赛勒佩特公司 | 小分子化合物 |
| JP2022514692A (ja) * | 2018-12-21 | 2022-02-14 | ユニバーシティ・オブ・ノートル・ダム・デュ・ラック | 抗酸菌症治療のためのｂｄオキシダーゼ阻害剤の発見 |
| MX2022003816A (es) | 2019-09-30 | 2022-05-06 | Janssen Sciences Ireland Unlimited Co | Compuestos antibacterianos. |
| US20220389008A1 (en) | 2019-09-30 | 2022-12-08 | Janssen Sciences Ireland Unlimited Company | 4-quinolinone antibacterial compounds |
| IL293592A (en) | 2019-12-06 | 2022-08-01 | Vertex Pharma | Transduced tetrahydrofurans as sodium channel modulators |
| WO2022214519A1 (fr) | 2021-04-07 | 2022-10-13 | Janssen Sciences Ireland Unlimited Company | Composés antibactériens |
| WO2022214520A1 (fr) | 2021-04-07 | 2022-10-13 | Janssen Sciences Ireland Unlimited Company | Composés antibactériens |
| EP4347031A1 (fr) | 2021-06-04 | 2024-04-10 | Vertex Pharmaceuticals Incorporated | N-(hydroxyalkyl (hétéro)aryl) tétrahydrofuran carboxamides utilisés en tant que modulateurs de canaux sodiques |
| WO2023078252A1 (fr) | 2021-11-02 | 2023-05-11 | Flare Therapeutics Inc. | Agonistes inverses de pparg et leurs utilisations |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201020076D0 (en) * | 2010-11-26 | 2011-01-12 | Liverpool School Tropical Medicine | Antimalarial compounds |
-
2015
- 2015-12-16 GB GBGB1522232.6A patent/GB201522232D0/en not_active Ceased
-
2016
- 2016-12-16 CN CN201680081942.4A patent/CN108697705A/zh active Pending
- 2016-12-16 EP EP16822230.5A patent/EP3389659A1/fr active Pending
- 2016-12-16 WO PCT/GB2016/053972 patent/WO2017103615A1/fr active Application Filing
- 2016-12-16 MA MA044057A patent/MA44057A/fr unknown
- 2016-12-16 US US16/062,443 patent/US10799494B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017103615A1 (fr) | 2017-06-22 |
| US20190151305A1 (en) | 2019-05-23 |
| CN108697705A (zh) | 2018-10-23 |
| EP3389659A1 (fr) | 2018-10-24 |
| US10799494B2 (en) | 2020-10-13 |
| GB201522232D0 (en) | 2016-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA44057A (fr) | Produit combiné | |
| BR112016018655A2 (pt) | Linha de produtos de artigo absorvente | |
| FI20145090A (fi) | Kuitupohjainen tuote | |
| DK3508196T3 (da) | Aripiprazol-prodrugsammensætninger | |
| FR3044643B1 (fr) | Produit alimentaire emballe | |
| DK3307076T3 (da) | Podepartikelprodukt | |
| FR3028721B3 (fr) | Produit alimentaire | |
| BR112016025074A2 (pt) | produto de espuma | |
| DK3182958T4 (da) | Aripiprazol-prodrugsammensætninger | |
| ES1119860Y (es) | Caramelo | |
| FR3019990B3 (fr) | Produit medical | |
| UA34047S (uk) | Кондитерський виріб | |
| UA34046S (uk) | Кондитерський виріб | |
| UA30908S (uk) | Кондитерський виріб | |
| UA32177S (uk) | Кондитерський виріб | |
| ITUA20161476A1 (it) | Prodotto make-up | |
| UA32060S (uk) | Кондитерський виріб | |
| FI10787U1 (fi) | Tuote | |
| ITUA20161625A1 (it) | Prodotto truccante | |
| UA33196S (uk) | Кондитерський виріб | |
| UA32272S (uk) | Кулінарний виріб | |
| FI11029U1 (fi) | Akustinen tuote | |
| FI10983U1 (fi) | Rakennustuote | |
| UA31615S (uk) | Кондитерський виріб | |
| UA28922S (uk) | Кондитерський виріб |